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ABSTRACTS0525: AUGIS TRAINEE PRIZE WINNER: ANTIMICROBIAL PROPHYLAXIS
PRIOR TO PANCREATICO-DUODENECTOMY
Peter Thomson, Miruna David, Simon Bramhall, John Isaac,
Ravi Marudanayagam, Darius Mirza, Paolo Muiesan, Robert Sutcliffe.
Queen Elizabeth Hospital, Birmingham, UK.
Aim: At our unit, antimicrobial prophylaxis prior to pancreatico-duode-
nectomy (PD) consists of tazocin/ﬂuconazole in patients who had preop-
erative biliary drainage (PBD), or co-amoxiclav in patients without PBD.
The objective of this study was to determine the appropriateness of these
regimens by analysis of intraoperative bile samples.
Methods: Retrospective analysis of 60 consecutive patients who under-
went PD (May 2011 - April 2012). Data regarding intraoperative bile cul-
tures/sensitivities were recorded.
Results: Intraoperative bile samples were available in 33/36 patients who
underwent PBD, and were positive in 30 (91%): bacteria in 26 (single 13,
multiple 13) and fungi in 18. Bile samples were available in 16/24 patients
in the non-PBD group, of which 5 were positive (31%) for bacterial infec-
tion (single in all cases). In the PBD group, bacterial sensitivities were co-
amoxiclav 12/26, tazocin 20/26, meropenem+vancomycin 25/26 and cip-
roﬂoxacin/gentamicin+metronidazole 16/26. In the non-PBD group, sen-
sitivities were co-amoxiclav 3/5, tazocin 5/5, meropenem+vancomycin 5/5
and ciproﬂoxacin/gentamicin+metronidazole 4/5. Surgical site infections
occurred in 8% of the PBD group and 29% of the non-PBD group.
Conclusions: Anti-fungal prophylaxis is essential prior to pancreatico-
duodenectomy in patients who have undergone preoperative biliary
drainage. Regular review of intraoperative bile cultures and tailoring of
prophylactic antibiotic regimens is recommended.
0531: ROLE OF ENDOSCOPIC ULTRASOUND AND MULTIDIMENSIONAL
COMPTUED TOMOGRAPHY IN PREDICTING NEED FOR MESENTERIC
VEIN RESECTION IN PANCREATICODUODENECTOMY SPECIMENS e A
HISTOPATHOLOGICAL CORRELATION
Ronan Kelly, Tom Gallagher, Kevin Conlon, Emir Hoti, Donal Maguire,
Justin Geoghegan, Oscar Traynor. National Surgical Centre for Pancreatic
Cancer, St Vincent's University Hospital, Dublin, Ireland.
In locally advanced pancreatic cancer, portal vein resection has been
shown to be a safe and feasible procedure that increases the number of
patients who undergo curative resection with a survival beneﬁt.
A retrospective review of a prospectively maintained database of pan-
creaticoduodenectomy operations performed at National Surgical Centre
for Pancreatic Cancer over 36 months (2010-2012) was performed. We
looked at the pre-operative prediction of the need for venous resection
made at the time of multidisciplinary team evaluation of CT and EUS
ﬁndings based on current NCCN ‘borderline resectable’ criteria for venous
involvement.
Portal vein resection, with primary repair or reconstruction, was per-
formed in 20 of 218(9%) consecutive procedures. Diagnostic pre-operative
4-Phase CT-Pancreas had been performed in all cases where vein resection
was performed while additional EUS was performed in 15/20(75%).
Combined preoperative imaging predicted the need for resection in 10 of
20(50%) cases while CT alone predicted only 6/20(30%). The R0 resection
rate was 12/20(60%) with 17(85%) patients alive at follow-up.
Despite advances in multi-planar imaging, preoperative radiological
evaluation often underestimates the need for mesenteric vein resection.
All patients undergoing surgical resection for pancreatic cancer should be
consented and assessed for suitability to undergo major venous resection
and reconstruction.
0598: BASOwTHE ASSOCIATION OF CANCER SURGERY PRIZE WINNER:
DETERMINING COMPLETE CLINICAL RESPONSE OF RADIOLOGICALLY
DISAPPEARING COLORECTAL LIVER METASTASES AFTER CHEMO-
THERAPY AND HOW THEY SHOULD BE MANAGED
David Hunter 1, Ashish Shrestha 1, Duncan Spalding 2, Madhava Pai 2.
1 Imperial College, London, UK; 2Hammersmith Hospital, London, UK.
Aim: To determine if radiologically disappearing liver metastases (DLMs)
after chemotherapy correspond to a complete clinical response. The
treatment of DLMs was also assessed to determine whether they should be
resected or left insitu.
Methods: A retrospective review was carried out on 342 patients referred
for surgical opinion between January 2001 and January 2012. Twenty-eight patients showed evidence of at least one metastasis disappearing
radiologically after chemotherapy. 16 patients were subsequently eligible
for review, median follow up of 27.6 months (range 5.2 e 113.9 months).
Results: 35 metastases were identiﬁed in 16 patients. Twenty-eight me-
tastases disappeared on imaging. 10 patients had 15 DLMs left insitu and 6
patients had 13 DLMs resected. Complete clinical responsewas observed in
15 DLMs (53.6%) on follow up. Five showed no recurrence within one year
in those left insitu (33.3%) and 10 showed complete pathological response
after resection (76.9%). A signiﬁcantly reduced recurrence free survival was
observed in the insitu group, [6.3 vs 19.4 months (p<0.001)], but overall
survival was not signiﬁcantly different between the two groups (p¼0.12).
Conclusion: DLMs radiologically do not necessarily confer a complete
clinical response. They should be resected when possible but leaving them
insitu can be warranted.
0826: IS NORMAL MACROSCOPIC APPEARANCE OF THE GALLBLADDER
FOLLOWING CHOLECYSTECTOMY SUFFICIENT TO EXCLUDE
MALIGNANCY?
Christopher Emmett 1,2, Andrew Gilliam 1,2, Andrew Mitchell 1,2,
Paul Barrett 1,2. 1Darlington Memorial Hospital, County Durham, UK;
2University Hospital of North Durham, County Durham, UK.
Aims: Occasionally, histological examination of the gallbladder following
routine cholecystectomy reveals an incidental cancer. We aim to assess
whether inspection of the gallbladder postoperatively, followed by histo-
logical examination of macroscopically abnormal specimens only, could be
a safe and cost-effective alternative to routine histological examination in
every case.
Methods: Patients undergoing emergency or elective cholecystectomy
between 1 May 2003 and 1 September 2010 were included. Pathology
records were used to identify all gallbladder malignancies. Only gall-
bladder cancers picked up incidentally following cholecystectomy were
included. Pathology reports were reviewed to establish whether there was
a macroscopic abnormality.
Results: 4776 patients were identiﬁed, including 532 emergencies. Overall
median age was 54 years (range 14 e 95), Male:Female ¼ 1:3. Of these,
13(0.27%) were found to have cancer; these patents had amedian age of 68
years (range 48-84). 42% of cancer cases were emergency admissions (5
patients, data incomplete for one case) compared with 11% of benign cases
(527 patients) (P¼0.0068). Of the cancer cases, 5 gallbladder specimens
(38%) had no documented macroscopic abnormality.
Conclusions: Most cancers are suspected from macroscopic appearance
but a small number are not, and these may be missed. Emergency cases
and older patients are particularly at risk.
0846: PRE-OPERATIVE LIVER ENZYME PREDICTS SURVIVAL AND
RECURRENCE AFTER LIVER RESECTION FOR HEPATOCELLULAR CARCI-
NOMA ARISING FROM NON-CIRRHOTIC/NON-FIBROTIC LIVER: A EURO-
PEAN PERSPECTIVE
C.Y. Tan 2, V.S. Yip 1, G. Sarno 1, S. Staettner 1, M. Terlizzo 1, N. Misra 1,
S. Fenwick 1, H. Malik 1, P. Ghaneh 1, G. Poston 1. 1Department of
Hepatobiliary Surgery and Cellular Pathology, Aintree University Hospital,
Liverpool, UK; 2 School of Medicine, University of Liverpool, Liverpool, UK.
Background: HCC is uncommon in western countries. This study evalu-
ated outcomes and prognostic factors following hepatectomy for HCC
arising in non-cirrhotic/non-ﬁbrotic livers.
Methods: Over a 15-year period, patients undergoing hepatectomy for
HCC were identiﬁed from prospectively maintained database. Patient de-
mographics, pre-operative biochemical and hematological factors, intra-
and postoperative clinical details, and tumour pathology were analysed
against overall (OS) and disease progression-free (PFS) survival.
Results: 57 patients underwent hepatectomy for non-cirrhotic/non-
ﬁbrotic HCC during study period. Median PFS was 22 months and me-
dian OS was 37 months, with 3- and 5-year survival rates post-resection
of 48% and 39% respectively. 42% developed recurrent disease. In uni-
variate analysis, the liver enzyme ratio was a factor affecting both OS and
PFS (p¼0.002). There was a signiﬁcant trend towards poorer OS (Log
rank test, p¼0.04) for patients with poorly differentiated tumours
compared to well and moderately differentiated tumours. Using Cox
proportional hazard model analysis, pre-operative liver enzyme ratio
was an indenpendent factor for both OS(HR¼3.13, p<0.02) and
PFS(HR¼1.02, p¼0.04) post-hepatectomy. Poorly differentiated tumour
